CD40LG and myeloid sarcoma: Then, an increase in HHV-6-specific antibodies was associated with clinical relapses [182], while raised anti-HHV-6 early antigen (p41/38) IgM antibodies have been shown in patients with RRMS as compared to patients affected by other MS subtypes or other neurological/autoimmune diseases [183].